Drug recall · January 19, 2022
8.4% Sodium Bicarbonate Injection recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC., Lenoir, NC 28645, NDC 51754-5001-1
- Lots / codes
Lot #: C0001088/P0001317, Exp. Date 08/2023
- Quantity
- 18,960 vials
- Company
- Exela Pharma Sciences LLC, Lenoir, NC
- Distribution
- Nationwide within the United States
- Initiated
- January 11, 2022 · Voluntary: Firm initiated
- Classified
- January 13, 2022
- Reported
- January 19, 2022
- Ended
- December 2, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium bicarbonate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.